Kazakhstan

Kazakhstan’s pharmaceutical market is worth $1.2 billion. A major portion of this, up to 80%, is imported. Hence, Kazakhstan remains a very attractive market for foreign companies. Alkem operates in Kazakhstan through its subsidiary, The Pharma Network (TPN), set up in 2011.

We made our presence felt in a relatively short period of time with our wide range of products in varied therapy segments like Anti-infectives, Gastroenterology, Urology, and Probiotics. Alkem is a strong player in the Paediatric portfolio.

Alkem has a precise focus on brand building in Kazakh. Our brands Taxim-O tablet and Taxim-O forte are leaders in their respective segments. Our brands - Zocef, Pan, and Nuloc, are among the top 5 brands in their respective segments.

Today, Alkem is among the top 5 Indian companies in the prescription market (Viortis 2023).

Kazakh has been one of the prime focuses for ALKEM, and standing on the strong prescription base, we envision making big in this market with many new brand launches.

Contact Us :